investor.baxalta.com
Baxalta Incorporated - Investor RelationsBaxalta is a leading provider of therapeutic treatments that save lives. Invest in the future of pharmaceuticals today.
http://investor.baxalta.com/
Baxalta is a leading provider of therapeutic treatments that save lives. Invest in the future of pharmaceuticals today.
http://investor.baxalta.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Sunday
LOAD TIME
0.7 seconds
PAGES IN
THIS WEBSITE
11
SSL
EXTERNAL LINKS
107
SITE IP
93.191.169.37
LOAD TIME
0.732 sec
SCORE
6.2
Baxalta Incorporated - Investor Relations | investor.baxalta.com Reviews
https://investor.baxalta.com
Baxalta is a leading provider of therapeutic treatments that save lives. Invest in the future of pharmaceuticals today.
investor.baxalta.com
Baxalta Incorporated - Presentations - Investor Relations
http://investor.baxalta.com/events-and-presentations/presentations/default.aspx
Research and Education Grants. Research and Education Grants. Product Safety and Adverse Reporting. Shareholder and Stock Information. Shareholder and Stock Information. All information available through the links on this page is current only as of the date on which it was presented, and Baxalta does not undertake to update any statements included therein except as updated through subsequent communications. First Quarter 2016 Financial Results. April 28, 2016. Download this Presentation (PDF 860 KB).
Baxalta Incorporated - Shareholder and BXLT Stock Information
http://investor.baxalta.com/shareholder-and-stock-information/default.aspx
Research and Education Grants. Research and Education Grants. Product Safety and Adverse Reporting. Shareholder and Stock Information. Shareholder and Stock Information. Shareholder and Stock Information. Oct 21, 2016 05:00 PM. Pricing delayed 20 minutes. Shareholder and Stock Information. End of Day Stock Quote. Enter the code shown above. Research and Education Grants. Shareholder and Stock Information. Search and Apply for Jobs. Privacy and Cookie Policies. Powered By Q4 Inc.
Baxalta Incorporated - SEC Filings - Investor Relations
http://investor.baxalta.com/financial-information/sec-filings/default.aspx
Research and Education Grants. Research and Education Grants. Product Safety and Adverse Reporting. Shareholder and Stock Information. Shareholder and Stock Information. Jun 28, 2016. Annual Report of Employee Stock Plans. Jun 13, 2016. Termination of Registration of a Class of Security under Section 12(b). Jun 07, 2016. Jun 07, 2016. Statement of Changes in Beneficial Ownership. Jun 07, 2016. Statement of Changes in Beneficial Ownership. Jun 07, 2016. Statement of Changes in Beneficial Ownership. Jun 07...
Baxalta Incorporated - FAQs - Investor Relations
http://investor.baxalta.com/investor-resources/investor-faqs/default.aspx
Research and Education Grants. Research and Education Grants. Product Safety and Adverse Reporting. Shareholder and Stock Information. Shareholder and Stock Information. 1 What was the date of the separation of Baxalta Incorporated from Baxter International? 2 What is the date you must be registered as a shareholder (record date) in order to receive Baxalta shares? 3 Where can I find the cost basis for my shares? 5 What is Baxalta’s dividend policy? 6 Where is Baxalta traded? 12 What is Baxalta’s CUSIP?
Baxalta Incorporated - Events Calendar - Investor Relations
http://investor.baxalta.com/events-and-presentations/events-calendar/default.aspx
Research and Education Grants. Research and Education Grants. Product Safety and Adverse Reporting. Shareholder and Stock Information. Shareholder and Stock Information. There are no events scheduled at this time. First Quarter 2016 Financial Results. Thursday, Apr 28, 2016. Given the proposed definitive merger agreement with Shire plc announced on Jan. 11, 2016, Baxalta will not be hosting a quarterly earnings conference call. First Quarter 2016 Financial Results. Click here for Presentation. Baxalta to...
TOTAL PAGES IN THIS WEBSITE
11
error-new
http://www.baxalta.com/baxalta/about/leadership/executive-officers.page
Position on Public Access. Report Synopses and Lay Summaries. Research and Education Grants. Position on Public Access. Report Synopses and Lay Summaries. Research and Education Grants. You are leaving Baxalta.com. Regulatory restrictions and medical practices may vary from one country to another and, as a result, the information given in the site to which you are going may not be relevant to the country in which you are living. I do not want to leave. I have read, understand and agree.
error-new
http://www.baxalta.com/baxalta/collaborations/business-development.page
Position on Public Access. Report Synopses and Lay Summaries. Research and Education Grants. Position on Public Access. Report Synopses and Lay Summaries. Research and Education Grants. You are leaving Baxalta.com. Regulatory restrictions and medical practices may vary from one country to another and, as a result, the information given in the site to which you are going may not be relevant to the country in which you are living. I do not want to leave. I have read, understand and agree.
error-new
http://www.baxalta.com/baxalta/newsroom/company-facts.page
Position on Public Access. Report Synopses and Lay Summaries. Research and Education Grants. Position on Public Access. Report Synopses and Lay Summaries. Research and Education Grants. You are leaving Baxalta.com. Regulatory restrictions and medical practices may vary from one country to another and, as a result, the information given in the site to which you are going may not be relevant to the country in which you are living. I do not want to leave. I have read, understand and agree.
error-new
http://www.baxalta.com/baxalta/products/medications/all-marketed-products.page
Position on Public Access. Report Synopses and Lay Summaries. Research and Education Grants. Position on Public Access. Report Synopses and Lay Summaries. Research and Education Grants. You are leaving Baxalta.com. Regulatory restrictions and medical practices may vary from one country to another and, as a result, the information given in the site to which you are going may not be relevant to the country in which you are living. I do not want to leave. I have read, understand and agree.
error-new
http://www.baxalta.com/baxalta/products.page
Position on Public Access. Report Synopses and Lay Summaries. Research and Education Grants. Position on Public Access. Report Synopses and Lay Summaries. Research and Education Grants. You are leaving Baxalta.com. Regulatory restrictions and medical practices may vary from one country to another and, as a result, the information given in the site to which you are going may not be relevant to the country in which you are living. I do not want to leave. I have read, understand and agree.
error-new
http://www.baxalta.com/baxalta/collaborations/supplier-information.page
Position on Public Access. Report Synopses and Lay Summaries. Research and Education Grants. Position on Public Access. Report Synopses and Lay Summaries. Research and Education Grants. You are leaving Baxalta.com. Regulatory restrictions and medical practices may vary from one country to another and, as a result, the information given in the site to which you are going may not be relevant to the country in which you are living. I do not want to leave. I have read, understand and agree.
error-new
http://www.baxalta.com/baxalta/collaboration.page
Position on Public Access. Report Synopses and Lay Summaries. Research and Education Grants. Position on Public Access. Report Synopses and Lay Summaries. Research and Education Grants. You are leaving Baxalta.com. Regulatory restrictions and medical practices may vary from one country to another and, as a result, the information given in the site to which you are going may not be relevant to the country in which you are living. I do not want to leave. I have read, understand and agree.
error-new
http://www.baxalta.com/baxalta/linking-disclaimer.page
Position on Public Access. Report Synopses and Lay Summaries. Research and Education Grants. Position on Public Access. Report Synopses and Lay Summaries. Research and Education Grants. You are leaving Baxalta.com. Regulatory restrictions and medical practices may vary from one country to another and, as a result, the information given in the site to which you are going may not be relevant to the country in which you are living. I do not want to leave. I have read, understand and agree.
error-new
http://www.baxalta.com/baxalta/careers.page
Position on Public Access. Report Synopses and Lay Summaries. Research and Education Grants. Position on Public Access. Report Synopses and Lay Summaries. Research and Education Grants. You are leaving Baxalta.com. Regulatory restrictions and medical practices may vary from one country to another and, as a result, the information given in the site to which you are going may not be relevant to the country in which you are living. I do not want to leave. I have read, understand and agree.
error-new
http://www.baxalta.com/baxalta/newsroom-media.page
Position on Public Access. Report Synopses and Lay Summaries. Research and Education Grants. Position on Public Access. Report Synopses and Lay Summaries. Research and Education Grants. You are leaving Baxalta.com. Regulatory restrictions and medical practices may vary from one country to another and, as a result, the information given in the site to which you are going may not be relevant to the country in which you are living. I do not want to leave. I have read, understand and agree.
TOTAL LINKS TO THIS WEBSITE
107
investor.bankofthecarolinas.com
Bank of the Carolinas Corporation - Investor Relations
When you invest in our bank, you not only invest in our performance, but also in our core values. They are the guiding principles of our bank, and they reflect the way we believe in doing business. Our core values are as follows:. We treat our customers the way we expect to be treated. We exist to make a profit that equals or exceeds our peers. We employ honest people to deal with honest people. We challenge our employees to be better than they think they can be. Our behaviors must match our values.
Bankrate | Investor Relations | Investor Overview
1032 - 0.02. Q2 2015 Bankrate, Inc. Earnings Conference Call. 160;at 4:30 pm ET. Bankrate, Inc. at the Annual Needham Interconnect Conference. 160;at 8:00 am ET. Bankrate: Mortgage Rates Nose Higher. Millennials Delaying Milestones Due to Student Loans. Bankrate Reports Record Second Quarter 2015 Financial Results And Updated Guidance. Mortgage Closing Costs Drop Seven Percent to $1,847. Bankrate Schedules Conference Call to Discuss Second Quarter 2015 Earnings. There are currently no events scheduled.
Investor Relations | Banner
Skip to main content. Sign in to your. Only sign in to Online Banking is available at this time. Please enable JavaScript in your browser for other options. Register for Online Banking. News and Market Data. Investor Relations Contact Information. Investor Relations Site Map. As of August 14, 2015 -. Minimum 20 minute delay. Q2 2015 Conference Call and Webcast. Tuesday, July 21, 2015. Islanders Bank - www.islandersbank.com. Community Financial Corporation www.communityfc.com. Banner Corporation Declares ...
Banyan Tree Hotels and Resorts | Investor Relations
Http:/ www.banyantree.com/corporate-information/information. Banyan Tree Holdings Limited. Headquartered in Singapore, Banyan Tree Holdings Limited is a leading, international hospitality brand that manages and develops premium resorts, hotels and spas. Banyan Tree's innovative business model is based on seven business segments generating multiple income streams: hotel investment, hotel management, spa operations, gallery operations, hotel residences, property sales, and design and related services.
INVESTOR BARGAINS - Find & List Real Estate Investor Bargains
Fix and Flip Retail. 47, 000.00. Bargain Deal Fort Wayne Investment Apartment Complex For Sale. Fort Wayne, Indiana 46816. FIRE SALE Investor Special. Fort Wayne, Indiana 46803. Northside 2 Bedroom Rental Investment. 1012 N. Anthony Blvd. Fort Wayne, Indiana 46805. Investor Wholesales To The Public. Bargains To Flip Or Hold. Phone (260)436-5000 ext. 221. INVESTOR BARGAINS © 2015.
Baxalta Incorporated - Investor Relations
Research and Education Grants. Research and Education Grants. Product Safety and Adverse Reporting. Shareholder and Stock Information. Shareholder and Stock Information. 11:03 AM Aug 18, 2015. May 19, 2015 - 2015 Investor Conference - Baxalta. Latest Baxalta financial information. Meet the Leadership Team. Meet Baxalta’s Corporate Leadership Team. Shareholder and Stock Information. End of Day Stock Quote. Promise of the Baxalta Spark. Research and Education Grants. Shareholder and Stock Information.
Investor Relations | Baxter
It looks like your browser is outdated. For the best experience, please consider updating to the latest version or switching to another browser (Firefox, Chrome, Safari). Intended for US Audiences Only. Our Products and Expertise. IV Solutions and Premixed Drugs. IV Infusion Systems and Administration Sets. Pharmacy Automation, Software and Services. Clinical Center of Excellence. Ethics and Compliance Helpline. A commitment to investors. View our investors portal. Stock and dividend information. Baxter ...
Overview - Bayer Investor Relations
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Our Brand. Our Values. Our Contribution to a Better Life. Allergies a Common Disorder. Fit in Old Age. The Future of Agriculture and Food. Europe, Middle East and Africa. Europe, Middle East and Africa. Supplier Code of Conduct. Transfers of Value to Healthcare Professionals. Collaboration with Healthcare Professionals. Information and IT Security. Duties and Activities of the Board of Management.
Übersicht - Bayer Investor Relations
Bayer ist ein weltweit tätiges Unternehmen mit Kernkompetenzen auf den Life-Science-Gebieten Gesundheit und Agrarwirtschaft. Unsere Marke. Unsere Werte. Unser Beitrag für ein besseres Leben. Landwirtschaft und Ernährung der Zukunft. Bayer in aller Welt. Europa, Nahost and Afrika. Region Europa, Nahost and Afrika. Zuwendungen an medizinische Fachkreise. 2013 150 Jahre Bayer. Science For A Better Life -Tour. Bayer auf der Slush 2017. Research Das Bayer Forschungsmagazin. Produkte von A bis Z. In diesem Ber...
Bangladesh Building Systems Ltd. || Investor Relation
BANGLADESH BUILDING SYSTEMS Ltd. Pre-Engineered Steel Building Manufacturer). Last '5 Years' Financial Summary. PRICE SENSITIVE INFORMATION ON 13 NOVEMBER, 2014. PRICE SENSITIVE INFORMATION ON 13 NOVEMBER, 2014. PRICE SENSITIVE INFORMATION ON 24 March, 2013. PRICE SENSITIVE INFORMATION ON 03 December, 2013. PRICE SENSITIVE INFORMATION ON 28 October, 2013. Contract between BBSL and Viyallatex Group. Contract between BBSL and Viyallatex Group. Contract between BBSL and Viyallatex Group.
B/E Aerospace | Investor Relations | Overview
Reports and SEC Filings. Power to Deliver." data-text=". Access stock data, financial reports and shareholder services for B/E Aerospace, the world's leading manufacturer of cabin products for passenger aircraft. Access stock data, financial reports and shareholder services for B/E Aerospace, the world's leading manufacturer of cabin products for passenger aircraft. To download the B/E Aerospace / KLX Spin-off Stock Cost Basis Form 8937. In PDF format please click here. In PDF format please click here.
SOCIAL ENGAGEMENT